An In Vitro Model for Thyroid Autoimmunity

  • B. E. Wenzel
  • R. Gutekunst
  • S. Grammerstorf
  • P. C. Scriba

Abstract

Clinical observations have suggested an association between iodine intake and the occurance of autoimmune thyroiditis in man (1,2), while in areas with endemic goiter prevalence due to iodine deficiency a lower incident of Hashimoto’s thyroditis was found (3), Others, however, have contested these claims (4,5). Experimentally, this association has been demonstrated with genetically susceptible chicken (6), rats (7) and dogs (8) on a high iodized diet. In the present study, we were interested in the effect iodine would have on the functional immune response of human Tlymphocytes in co-cultures with autologous thyroid epithilial cells (TECs). Classically, only immunocompetent cells, namely macrophages are able to present antigen together with the immunregulatory class-II surface antigen(9)•These class-II antigens (in man HLA-D locii) can also be found in vivo (10) and induced by various agents in vitro(11) on TECs. With this background our in vitro model system was designed to i) modulate HLA-D expression on TECs and ii) to investigate,if a potential iodide induced autoantigen on TECs would be presented through HLA-D to autologous T-lymphocytes and thus initiate a proliferative cellular immunresponse. In order to modulate the hypothetical iodine induced autoantigen the influence of Methimazole (MMI) and perchlorate (PC) on the co-culture system was to be studied. MMI has been suspected to act immune suppressively during suppression therapy of Graves’ disease (GD) in vivo and on antibody synthesis in vitro (12). Interestingly, when MMI therapy in GD hyperthyroidism was compared to PC treatment, which clearly is no immuno suppressive agent, both drugs had the same effect on the production of thyroid stimulating antibodies (TSab) (13).

Keywords

Cellulose Europe Iodine Hydrocortisone Iodide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Furszyfer J, Kurland LT, McConahey WM, Wooler BL, Elverback LR, Epidemiologic Aspects of Hashimoto’s and Graves’Disease in Rochester,Minnesota(1935- 1967) With Special Reference to Temporal Trends. Metabolism,21/3: 197,(1972).CrossRefGoogle Scholar
  2. 2.
    FradkinJE, Wolff J. Iodide-induced thyrotoxicosis. Medicine, 62/1: 1, (1983).Google Scholar
  3. 3.
    Asamer H, Riccabona G, Holthaus N, Gabel F. Immunhistologische Befunde bei Schilddriisenerkrankungen in den endemischen Kropfgebiet. Archiv fur Klinische Medizin 215 : 270,(1968).PubMedGoogle Scholar
  4. 4.
    Vollweider R, Stolkin I, Hedinger C. Fokale lymphozytare Thyreoditis und Jodsalzprophylaxe. Schweizer Med Wschr 112: 482, (1982).Google Scholar
  5. 5.
    Harach HR, Escalante DA, Onativia A, Outes JL, Day ES, Williams ED. Thyroid carcinoma and thyroiditis an endemic goiter region before and after iodine prophylaxis. Acta Endocrinol(Kbh) 108: 55, (1985).Google Scholar
  6. 6.
    Bagchi N, Brown TR, Urdanivia E, Sundick RS. Induction of autoimmune thyroiditis in chicken by dietary iodine. Science 230: 325,(1985).PubMedCrossRefGoogle Scholar
  7. 7.
    Allen EM, Appel MC, Braverman LE. The effect of iodide ingestion on the develpement of spontaneous lymphocytic thyrioditis in the diabetes-prone BB/W rat. Endocrinol 118 : 1977,(1986).CrossRefGoogle Scholar
  8. 8.
    Evans TC, Beierwaltes WH, Nishiyama RH. Eperimental canine Hashimoto’s thyrioditis. Endocrinology 84: 641, (1969).PubMedCrossRefGoogle Scholar
  9. 9.
    Balfour BM, Drexhage HA, Kamperdijk EWA, Hoefsmit ECM. Antigen-presenting cells,including Langerhans’ cells,veiled cells and interdigitating cells; in microenvironments in haemopoietic and lymphoid differentiations. Ciba Symp 84: 28l,(1981)Google Scholar
  10. 10.
    Hafanusa T, Pujol-Borrell R, Chiovato L, Russel RCG, Doniach D, Bottazzo GF. Aberrant expression of HLADR antigen on thyrocytes in Graves’ disease: relevance for auto-immunity. Lancet ii: 1111,(1983).Google Scholar
  11. 11.
    Wenzel BE, Gutekunst R, Mansky T, Schultek T, Scriba PC. Thyrotropin and IgG from patients with Graves’ disease induce class-II antigen on human thyroid cells. In:The thyroid and autoimmunity, eds. H.A. Drexhage and W,M. Wiersinga;p. 141Elsevier,(1986).Google Scholar
  12. 12.
    McGregor AM, Petersen MM, McLachlan SM, Rocke P, Smith BR, Hall R. Carbimazole and the autoimmune response in Graves `disease. N Engl J Med 303: 302, (1980).PubMedCrossRefGoogle Scholar
  13. 13.
    Wenzel KW, Lente JR. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating Immunoglobulins in Graves’disease: Evidence against an immunosuppressive action of thionamide drugs. J Clin Endocrinol Metab 58: 62, (1984).PubMedCrossRefGoogle Scholar
  14. 14.
    Londei M, Lamb JR, Bottazzo GF, Feldmann M. Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T-cell. Nature 312: 639,(1984).PubMedCrossRefGoogle Scholar
  15. 15.
    Carel JC, Remy JJ, Zuchman D, Salamero J, Charreire J. Role of Methimazole on DR antugen expression on human thyroid epithelial cell cultures, in: The thyroid and autoimmunity;eds. H.A.Drexhage and W.M.Wiersinga.Elsevier, (1986)Google Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • B. E. Wenzel
    • 1
  • R. Gutekunst
    • 1
  • S. Grammerstorf
    • 1
  • P. C. Scriba
    • 1
  1. 1.Klinik für Innere MedizinMed. Universität zu LübeckLübeckFR Germany

Personalised recommendations